1. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
- Author
-
Bollini M, Casal JJ, Alvarez DE, Boiani L, González M, Cerecetto H, and Bruno AM
- Subjects
- Animals, Chagas Disease drug therapy, Dose-Response Relationship, Drug, Glutathione chemistry, Glutathione metabolism, HeLa Cells, Humans, Imidazoles metabolism, Imidazoles toxicity, Isoquinolines metabolism, Isoquinolines toxicity, Models, Molecular, Oxidation-Reduction drug effects, Quantitative Structure-Activity Relationship, Trypanocidal Agents metabolism, Trypanocidal Agents pharmacology, Trypanocidal Agents toxicity, DNA, Protozoan metabolism, Imidazoles chemistry, Imidazoles pharmacology, Isoquinolines chemistry, Isoquinolines pharmacology, Trypanocidal Agents chemical synthesis, Trypanosoma cruzi drug effects
- Abstract
A series of novel benzoimidazo and N-aryl-5-oxo-imidazo[1,2-b]isoquinoline-10-carbothioamides was developed. All the compounds were evaluated for their in vitro action against the epimastigote form of Trypanosoma cruzi. Four of them showed higher activity than Nifurtimox. Their unspecific cytotoxicity was evaluated using HeLa and L6 cells, being non-toxic at concentrations at least 15 and 200 times higher than that of T. cruzi IC(50.) To gain insight into the mechanism of action, their DNA binding properties and reactivity with glutathione were studied, and QSAR study was performed.
- Published
- 2009
- Full Text
- View/download PDF